<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Williamson SR</dc:creator>
  <dc:creator>Gadde R</dc:creator>
  <dc:creator>Trpkov K</dc:creator>
  <dc:creator>Hirsch MS</dc:creator>
  <dc:creator>Srigley JR</dc:creator>
  <dc:creator>Reuter VE</dc:creator>
  <dc:creator>Cheng L</dc:creator>
  <dc:creator>Kunju LP</dc:creator>
  <dc:creator>Barod R</dc:creator>
  <dc:creator>Rogers CG</dc:creator>
  <dc:creator>Delahunt B</dc:creator>
  <dc:creator>Hes O</dc:creator>
  <dc:creator>Eble JN</dc:creator>
  <dc:creator>Zhou M</dc:creator>
  <dc:creator>McKenney JK</dc:creator>
  <dc:creator>Martignoni G</dc:creator>
  <dc:creator>Fleming S</dc:creator>
  <dc:creator>Grignon DJ</dc:creator>
  <dc:creator>Moch H</dc:creator>
  <dc:creator>Gupta NS</dc:creator>
  <dc:date>2017</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Renal oncocytoma and chromophobe renal cell carcinoma have been long recognized as distinct tumors; however, it remains unknown if uniform diagnostic criteria are used to distinguish these tumor types in practice. A survey was distributed to urologic pathologists regarding oncocytic tumors. Responses were received from 17 of 26 invitees. Histologically, more than 1 mitotic figure was regarded as most worrisome (n=10) or incompatible (n=6) with oncocytoma diagnosis. Interpretation of focal nuclear wrinkling, focal perinuclear clearing, and multinucleation depended on extent and did not necessarily exclude oncocytoma if minor. Staining techniques most commonly used included the following: cytokeratin 7 (94%), KIT (71%), vimentin (65%), colloidal iron (59%), CD10 (53%), and AMACR (41%). Rare cytokeratin 7-positive cells (≤5%) were regarded as most supportive of oncocytoma, although an extent excluding oncocytoma was not universal. Multiple chromosomal losses were most strongly supportive for chromophobe renal cell carcinoma diagnosis (65%). Less certainty was reported for chromosomal gain or a single loss. For tumors with mixed or inconclusive features, many participants use an intermediate diagnostic category (82%) that does not label the tumor as unequivocally benign or malignant, typically "oncocytic neoplasm" or "tumor" with comment. The term "hybrid tumor" was used variably in several scenarios. A slight majority (65%) report outright diagnosis of oncocytoma in needle biopsies. The morphologic, immunohistochemical, and genetic characteristics that define oncocytic renal tumors remain incompletely understood. Further studies correlating genetics, behavior, and histology are needed to define which tumors truly warrant classification as carcinomas for patient counseling and follow-up strategies.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://sonar.ch/global/documents/258542</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1016/j.humpath.2017.03.004</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/28315424</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:source>Human pathology. - 2017</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Chromophobe renal cell carcinoma</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Diagnostic criteria</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Hybrid tumor</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Immunohistochemistry</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Oncocytoma</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Tumor classification</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Adenoma, Oxyphilic</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Biomarkers, Tumor</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Biopsy</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Carcinoma, Renal Cell</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Cell Proliferation</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Diagnosis, Differential</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Health Care Surveys</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Immunohistochemistry</dc:subject>
  <dc:subject xmlns:ns16="xml" ns16:lang="en">Keratin-7</dc:subject>
  <dc:subject xmlns:ns17="xml" ns17:lang="en">Kidney Neoplasms</dc:subject>
  <dc:subject xmlns:ns18="xml" ns18:lang="en">Mitotic Index</dc:subject>
  <dc:subject xmlns:ns19="xml" ns19:lang="en">Molecular Diagnostic Techniques</dc:subject>
  <dc:subject xmlns:ns20="xml" ns20:lang="en">Pathologists</dc:subject>
  <dc:subject xmlns:ns21="xml" ns21:lang="en">Predictive Value of Tests</dc:subject>
  <dc:subject xmlns:ns22="xml" ns22:lang="en">Prognosis</dc:subject>
  <dc:subject xmlns:ns23="xml" ns23:lang="en">Urologists</dc:subject>
  <dc:title xmlns:ns24="xml" ns24:lang="en">Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
